β‑catenin regulates effects of miR‑24 on the viability and autophagy of glioma cells

Mutations of the β-catenin gene are common in various cancer types. MicroRNA (miR)-24 suppresses gene expression during the cell cycle. However, the effects of miR-24 on the cell viability and autophagy of glioma cells, and how these biological processes are regulated by β-catenin are largely unclea...

Full description

Saved in:
Bibliographic Details
Published inExperimental and therapeutic medicine Vol. 18; no. 2; pp. 1285 - 1290
Main Authors Chen, Hanchun, Lu, Qiong, Chen, Chao, Di, Yunhai, Li, Ya'nan, Min, Weijie, Yu, Zhengquan, Dai, Dongwei
Format Journal Article
LanguageEnglish
Published Greece Spandidos Publications UK Ltd 01.08.2019
D.A. Spandidos
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Mutations of the β-catenin gene are common in various cancer types. MicroRNA (miR)-24 suppresses gene expression during the cell cycle. However, the effects of miR-24 on the cell viability and autophagy of glioma cells, and how these biological processes are regulated by β-catenin are largely unclear. The current study aimed to investigate the role of β-catenin in regulating the effects of miR-24 on the cell viability and autophagy of glioma cells. The expression levels of microtubule-associated proteins 1A/1B light chain 3B (LC3B) and Beclin1 were detected by immunohistochemistry and western blotting. Glioma C6 cells were transfected with miR-24 mimics, miR-24 inhibitors and negative control miRNAs. C6 cells transfected with miR-24 mimics or negative control miRNAs were treated with the β-catenin inhibitor, XAV-939. An MTT assay was utilized to evaluate the viability of C6 cells. The expression of miR-24 and mRNA expression of autophagy related 4a cysteine peptidase (ATG4A) were detected by quantitative polymerase chain reaction analysis. The protein expression of LC3B and Beclin1 decreased significantly in glioma tissue and glioma C6 cells compared with normal brain tissue. Compared with the negative control group, C6 cells transfected with miR-24 mimics exhibited significantly higher cell viability at 24 and 48 h, and those transfected with miR-24 inhibitors exhibited significantly lower cell viability at 48 h. XAV-939 decreased the stimulatory effects of miR-24 mimics on the viability of C6 cells. The expression of miR-24 significantly decreased and ATG4A mRNA significantly increased in C6 cells transfected with XAV-939 compared with those transfected with the negative control miRNA. XAV-939 attenuated the miR-24-induced decrease of the protein expression of LC3B and Beclin1, and decreased the stimulatory effects of miR-24 mimics on cell viability. In addition, XAV-939 attenuated the miR-24-induced decrease of autophagy marker expression by attenuating miR-24 expression and increasing ATG4A mRNA expression in glioma C6 cells. To the best of our knowledge, the present study is the first to demonstrate whether β-catenin regulates the intracellular effects of miR-24 on the viability and autophagy of glioma cells. The results also provide some mechanistic basis to the pharmaceutical targeting of WNT signaling in high grade glial tumors.
AbstractList Mutations of the β-catenin gene are common in various cancer types. MicroRNA (miR)-24 suppresses gene expression during the cell cycle. However, the effects of miR-24 on the cell viability and autophagy of glioma cells, and how these biological processes are regulated by β-catenin are largely unclear. The current study aimed to investigate the role of β-catenin in regulating the effects of miR-24 on the cell viability and autophagy of glioma cells. The expression levels of microtubule-associated proteins 1A/1B light chain 3B (LC3B) and Beclin1 were detected by immunohistochemistry and western blotting. Glioma C6 cells were transfected with miR-24 mimics, miR-24 inhibitors and negative control miRNAs. C6 cells transfected with miR-24 mimics or negative control miRNAs were treated with the β-catenin inhibitor, XAV-939. An MTT assay was utilized to evaluate the viability of C6 cells. The expression of miR-24 and mRNA expression of autophagy related 4a cysteine peptidase (ATG4A) were detected by quantitative polymerase chain reaction analysis. The protein expression of LC3B and Beclin1 decreased significantly in glioma tissue and glioma C6 cells compared with normal brain tissue. Compared with the negative control group, C6 cells transfected with miR-24 mimics exhibited significantly higher cell viability at 24 and 48 h, and those transfected with miR-24 inhibitors exhibited significantly lower cell viability at 48 h. XAV-939 decreased the stimulatory effects of miR-24 mimics on the viability of C6 cells. The expression of miR-24 significantly decreased and ATG4A mRNA significantly increased in C6 cells transfected with XAV-939 compared with those transfected with the negative control miRNA. XAV-939 attenuated the miR-24-induced decrease of the protein expression of LC3B and Beclin1, and decreased the stimulatory effects of miR-24 mimics on cell viability. In addition, XAV-939 attenuated the miR-24-induced decrease of autophagy marker expression by attenuating miR-24 expression and increasing ATG4A mRNA expression in glioma C6 cells. To the best of our knowledge, the present study is the first to demonstrate whether β-catenin regulates the intracellular effects of miR-24 on the viability and autophagy of glioma cells. The results also provide some mechanistic basis to the pharmaceutical targeting of WNT signaling in high grade glial tumors.
Mutations of the β-catenin gene are common in various cancer types. MicroRNA (miR)-24 suppresses gene expression during the cell cycle. However, the effects of miR-24 on the cell viability and autophagy of glioma cells, and how these biological processes are regulated by β-catenin are largely unclear. The current study aimed to investigate the role of β-catenin in regulating the effects of miR-24 on the cell viability and autophagy of glioma cells. The expression levels of microtubule-associated proteins 1A/1B light chain 3B (LC3B) and Beclin1 were detected by immunohistochemistry and western blotting. Glioma C6 cells were transfected with miR-24 mimics, miR-24 inhibitors and negative control miRNAs. C6 cells transfected with miR-24 mimics or negative control miRNAs were treated with the β-catenin inhibitor, XAV-939. An MTT assay was utilized to evaluate the viability of C6 cells. The expression of miR-24 and mRNA expression of autophagy related 4a cysteine peptidase (ATG4A) were detected by quantitative polymerase chain reaction analysis. The protein expression of LC3B and Beclin1 decreased significantly in glioma tissue and glioma C6 cells compared with normal brain tissue. Compared with the negative control group, C6 cells transfected with miR-24 mimics exhibited significantly higher cell viability at 24 and 48 h, and those transfected with miR-24 inhibitors exhibited significantly lower cell viability at 48 h. XAV-939 decreased the stimulatory effects of miR-24 mimics on the viability of C6 cells. The expression of miR-24 significantly decreased and ATG4A mRNA significantly increased in C6 cells transfected with XAV-939 compared with those transfected with the negative control miRNA. XAV-939 attenuated the miR-24-induced decrease of the protein expression of LC3B and Beclin1, and decreased the stimulatory effects of miR-24 mimics on cell viability. In addition, XAV-939 attenuated the miR-24-induced decrease of autophagy marker expression by attenuating miR-24 expression and increasing ATG4A mRNA expression in glioma C6 cells. To the best of our knowledge, the present study is the first to demonstrate whether β-catenin regulates the intracellular effects of miR-24 on the viability and autophagy of glioma cells. The results also provide some mechanistic basis to the pharmaceutical targeting of WNT signaling in high grade glial tumors.Mutations of the β-catenin gene are common in various cancer types. MicroRNA (miR)-24 suppresses gene expression during the cell cycle. However, the effects of miR-24 on the cell viability and autophagy of glioma cells, and how these biological processes are regulated by β-catenin are largely unclear. The current study aimed to investigate the role of β-catenin in regulating the effects of miR-24 on the cell viability and autophagy of glioma cells. The expression levels of microtubule-associated proteins 1A/1B light chain 3B (LC3B) and Beclin1 were detected by immunohistochemistry and western blotting. Glioma C6 cells were transfected with miR-24 mimics, miR-24 inhibitors and negative control miRNAs. C6 cells transfected with miR-24 mimics or negative control miRNAs were treated with the β-catenin inhibitor, XAV-939. An MTT assay was utilized to evaluate the viability of C6 cells. The expression of miR-24 and mRNA expression of autophagy related 4a cysteine peptidase (ATG4A) were detected by quantitative polymerase chain reaction analysis. The protein expression of LC3B and Beclin1 decreased significantly in glioma tissue and glioma C6 cells compared with normal brain tissue. Compared with the negative control group, C6 cells transfected with miR-24 mimics exhibited significantly higher cell viability at 24 and 48 h, and those transfected with miR-24 inhibitors exhibited significantly lower cell viability at 48 h. XAV-939 decreased the stimulatory effects of miR-24 mimics on the viability of C6 cells. The expression of miR-24 significantly decreased and ATG4A mRNA significantly increased in C6 cells transfected with XAV-939 compared with those transfected with the negative control miRNA. XAV-939 attenuated the miR-24-induced decrease of the protein expression of LC3B and Beclin1, and decreased the stimulatory effects of miR-24 mimics on cell viability. In addition, XAV-939 attenuated the miR-24-induced decrease of autophagy marker expression by attenuating miR-24 expression and increasing ATG4A mRNA expression in glioma C6 cells. To the best of our knowledge, the present study is the first to demonstrate whether β-catenin regulates the intracellular effects of miR-24 on the viability and autophagy of glioma cells. The results also provide some mechanistic basis to the pharmaceutical targeting of WNT signaling in high grade glial tumors.
Author Min, Weijie
Di, Yunhai
Chen, Chao
Dai, Dongwei
Chen, Hanchun
Lu, Qiong
Li, Ya'nan
Yu, Zhengquan
AuthorAffiliation 2 Department of Laboratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
4 Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China
1 Department of Neurosurgery, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Suzhou, Jiangsu 215021, P.R. China
3 Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
AuthorAffiliation_xml – name: 2 Department of Laboratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
– name: 3 Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
– name: 4 Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China
– name: 1 Department of Neurosurgery, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Suzhou, Jiangsu 215021, P.R. China
Author_xml – sequence: 1
  givenname: Hanchun
  surname: Chen
  fullname: Chen, Hanchun
  organization: Department of Neurosurgery, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Suzhou, Jiangsu 215021, P.R. China
– sequence: 2
  givenname: Qiong
  surname: Lu
  fullname: Lu, Qiong
  organization: Department of Laboratory Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
– sequence: 3
  givenname: Chao
  surname: Chen
  fullname: Chen, Chao
  organization: Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
– sequence: 4
  givenname: Yunhai
  surname: Di
  fullname: Di, Yunhai
  organization: Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
– sequence: 5
  givenname: Ya'nan
  surname: Li
  fullname: Li, Ya'nan
  organization: Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
– sequence: 6
  givenname: Weijie
  surname: Min
  fullname: Min, Weijie
  organization: Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
– sequence: 7
  givenname: Zhengquan
  surname: Yu
  fullname: Yu, Zhengquan
  organization: Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China
– sequence: 8
  givenname: Dongwei
  surname: Dai
  fullname: Dai, Dongwei
  organization: Department of Neurosurgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31316620$$D View this record in MEDLINE/PubMed
BookMark eNptkc9KHTEUxkNR1FqX3ZaAGzdzzZ9JJtkIIvYPCAVpF12FTCa5NzKTXCcZ4e58BV_FB-lD9Emawau0YhbJgfzOx3fO9x7shBgsAB8xWlAhyanNw4IgLBcNF-gdOMCNJBVGmO1sayQF3gdHKd2gchjHQrA9sE8xxZwTdAB-_X78c_9gdLbBBzja5dSXOkHrnDU5wejg4K8LQmoYA8wrC--8bn3v8wbq0EE95bhe6eVmRpe9j4OGxvZ9-gB2ne6TPdq-h-Dn58sfF1-rq-9fvl2cX1WG1ixX1BJHtJG1dg3lbSctc43gXMpyCWGkqdsWS6RNbZjmpnG6Y22L2qarOUYdPQRnT7rrqR1sZ2zIo-7VevSDHjcqaq_-_wl-pZbxTnGOMKasCJxsBcZ4O9mU1eDTPIIONk5JEcKkRLJmTUGPX6E3cRpDGa9QvDCYcFGoT_86erHyvPUC0CfAjDGl0TplfNbZx9mg7xVGao5XlXjVHK-a4y1d1auuZ-G3-b9q2anP
CitedBy_id crossref_primary_10_3389_fonc_2020_597743
crossref_primary_10_3389_fphar_2019_01262
Cites_doi 10.1136/gutjnl-2015-310625
10.18632/oncotarget.2787
10.1083/jcb.201203134
10.1016/j.devcel.2009.06.016
10.1074/jbc.R600027200
10.3892/mmr.2015.4664
10.1371/journal.pone.0001864
10.18632/oncotarget.13550
10.1007/s11060-011-0793-0
10.1016/j.cancergen.2012.10.009
10.18632/oncotarget.11699
10.1038/srep22966
10.1182/blood-2007-05-092718
10.1016/j.febslet.2014.06.017
10.1006/meth.2001.1262
10.1016/j.taap.2013.09.021
10.1083/jcb.201002108
10.1038/nature08356
10.1007/s13277-015-3892-2
10.1158/1535-7163.MCT-15-0857
10.1016/j.canlet.2015.02.003
10.1016/j.molcel.2009.08.020
10.3389/fncel.2017.00318
10.1111/j.1365-2133.2004.06048.x
10.1007/s10753-016-0370-y
10.1002/path.4725
ContentType Journal Article
Copyright Copyright Spandidos Publications UK Ltd. 2019
Copyright © 2019, Spandidos Publications 2019
Copyright_xml – notice: Copyright Spandidos Publications UK Ltd. 2019
– notice: Copyright © 2019, Spandidos Publications 2019
DBID AAYXX
CITATION
NPM
3V.
7RV
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AN0
BENPR
CCPQU
FYUFA
GHDGH
K9.
KB0
M0S
NAPCQ
PHGZM
PHGZT
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.3892/etm.2019.7680
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database (Proquest)
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
British Nursing Index with Full Text
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1792-1015
EndPage 1290
ExternalDocumentID PMC6601135
31316620
10_3892_etm_2019_7680
Genre Journal Article
GeographicLocations Beijing China
United States--US
China
GeographicLocations_xml – name: China
– name: Beijing China
– name: United States--US
GroupedDBID ---
0R~
53G
7RV
7X7
8FI
8FJ
AAKDD
AAYXX
ABDBF
ABJNI
ABUWG
ACGFS
ACUHS
ADBBV
AENEX
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AN0
BENPR
BKEYQ
BNQBC
BPHCQ
BVXVI
C45
CCPQU
CITATION
EBD
EBS
EJD
ESX
F5P
FYUFA
H13
HMCUK
HUR
HZ~
IAO
IHR
IPNFZ
ITC
NAPCQ
O9-
OVD
PHGZM
PHGZT
PQQKQ
PROAC
RIG
RPM
TEORI
UKHRP
3V.
NPM
OK1
7XB
8FK
K9.
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c345t-3e2f2ac94af736bd9e5f78669986688c9c4bb190ac4c5a6c7fad5bb0b7d4610d3
IEDL.DBID 7X7
ISSN 1792-0981
IngestDate Thu Aug 21 17:47:03 EDT 2025
Fri Jul 11 15:10:49 EDT 2025
Sat Aug 23 13:09:09 EDT 2025
Thu Jan 02 23:04:08 EST 2025
Tue Jul 01 03:33:31 EDT 2025
Thu Apr 24 22:55:17 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 2
Keywords microRNA-24
β-catenin
autophagy
cell viability
glioma C6 cells
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c345t-3e2f2ac94af736bd9e5f78669986688c9c4bb190ac4c5a6c7fad5bb0b7d4610d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Contributed equally
OpenAccessLink http://www.spandidos-publications.com/10.3892/etm.2019.7680/download
PMID 31316620
PQID 2260941268
PQPubID 2044959
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6601135
proquest_miscellaneous_2259909457
proquest_journals_2260941268
pubmed_primary_31316620
crossref_citationtrail_10_3892_etm_2019_7680
crossref_primary_10_3892_etm_2019_7680
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-08-01
PublicationDateYYYYMMDD 2019-08-01
PublicationDate_xml – month: 08
  year: 2019
  text: 2019-08-01
  day: 01
PublicationDecade 2010
PublicationPlace Greece
PublicationPlace_xml – name: Greece
– name: Athens
PublicationTitle Experimental and therapeutic medicine
PublicationTitleAlternate Exp Ther Med
PublicationYear 2019
Publisher Spandidos Publications UK Ltd
D.A. Spandidos
Publisher_xml – name: Spandidos Publications UK Ltd
– name: D.A. Spandidos
References Wei (key20200713100450_b9-etm-0-0-7680) 2016; 7
Lal (key20200713100450_b11-etm-0-0-7680) 2008; 3
Wang (key20200713100450_b14-etm-0-0-7680) 2008; 111
Yin (key20200713100450_b15-etm-0-0-7680) 2016; 7
Cui (key20200713100450_b20-etm-0-0-7680) 2016; 239
Bleeker (key20200713100450_b2-etm-0-0-7680) 2012; 108
Singh (key20200713100450_b7-etm-0-0-7680) 2013; 273
Amelio (key20200713100450_b13-etm-0-0-7680) 2012; 199
Saldanha (key20200713100450_b4-etm-0-0-7680) 2004; 151
Pan (key20200713100450_b16-etm-0-0-7680) 2015; 6
MacDonald (key20200713100450_b5-etm-0-0-7680) 2009; 17
Guo (key20200713100450_b23-etm-0-0-7680) 2015; 360
Goodenberger (key20200713100450_b1-etm-0-0-7680) 2012; 205
Lal (key20200713100450_b12-etm-0-0-7680) 2009; 35
Livak (key20200713100450_b19-etm-0-0-7680) 2001; 25
McCord (key20200713100450_b26-etm-0-0-7680) 2017; 11
Liu (key20200713100450_b24-etm-0-0-7680) 2016; 13
Dong (key20200713100450_b8-etm-0-0-7680) 2016; 6
Cherra (key20200713100450_b17-etm-0-0-7680) 2010; 190
Tao (key20200713100450_b6-etm-0-0-7680) 2016; 37
Tian (key20200713100450_b25-etm-0-0-7680) 2016; 39
Chen (key20200713100450_b10-etm-0-0-7680) 2016; 65
Weis (key20200713100450_b3-etm-0-0-7680) 2006; 281
Yan (key20200713100450_b22-etm-0-0-7680) 2014; 588
Huang (key20200713100450_b18-etm-0-0-7680) 2009; 461
Wu (key20200713100450_b21-etm-0-0-7680) 2016; 15
References_xml – volume: 65
  start-page: 1522
  year: 2016
  ident: key20200713100450_b10-etm-0-0-7680
  article-title: The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway
  publication-title: Gut
  doi: 10.1136/gutjnl-2015-310625
– volume: 6
  start-page: 317
  year: 2015
  ident: key20200713100450_b16-etm-0-0-7680
  article-title: Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.2787
– volume: 199
  start-page: 347
  year: 2012
  ident: key20200713100450_b13-etm-0-0-7680
  article-title: miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migration
  publication-title: J Cell Biol
  doi: 10.1083/jcb.201203134
– volume: 17
  start-page: 9
  year: 2009
  ident: key20200713100450_b5-etm-0-0-7680
  article-title: Wnt/beta-catenin signaling: Components, mechanisms, and diseases
  publication-title: Dev Cell
  doi: 10.1016/j.devcel.2009.06.016
– volume: 281
  start-page: 35593
  year: 2006
  ident: key20200713100450_b3-etm-0-0-7680
  article-title: Re-solving the cadherin-catenin-actin conundrum
  publication-title: J Biol Chem
  doi: 10.1074/jbc.R600027200
– volume: 13
  start-page: 1389
  year: 2016
  ident: key20200713100450_b24-etm-0-0-7680
  article-title: Tissue kallikrein promotes survival and β-catenin degradation in SH-SY5Y cells under nutrient stress conditions via autophagy
  publication-title: Mol Med Rep
  doi: 10.3892/mmr.2015.4664
– volume: 3
  start-page: e1864
  year: 2008
  ident: key20200713100450_b11-etm-0-0-7680
  article-title: p16(INK4a) translation suppressed by miR-24
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0001864
– volume: 7
  start-page: 86755
  year: 2016
  ident: key20200713100450_b15-etm-0-0-7680
  article-title: TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.13550
– volume: 108
  start-page: 11
  year: 2012
  ident: key20200713100450_b2-etm-0-0-7680
  article-title: Recent advances in the molecular understanding of glioblastoma
  publication-title: J Neurooncol
  doi: 10.1007/s11060-011-0793-0
– volume: 205
  start-page: 613
  year: 2012
  ident: key20200713100450_b1-etm-0-0-7680
  article-title: Genetics of adult glioma
  publication-title: Cancer Genet
  doi: 10.1016/j.cancergen.2012.10.009
– volume: 7
  start-page: 65374
  year: 2016
  ident: key20200713100450_b9-etm-0-0-7680
  article-title: ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.11699
– volume: 6
  start-page: 22966
  year: 2016
  ident: key20200713100450_b8-etm-0-0-7680
  article-title: The Wnt/β-catenin signaling/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cells
  publication-title: Sci Rep
  doi: 10.1038/srep22966
– volume: 111
  start-page: 588
  year: 2008
  ident: key20200713100450_b14-etm-0-0-7680
  article-title: MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4
  publication-title: Blood
  doi: 10.1182/blood-2007-05-092718
– volume: 588
  start-page: 3038
  year: 2014
  ident: key20200713100450_b22-etm-0-0-7680
  article-title: miR-96/HBP1/Wnt/β-catenin regulatory circuitry promotes glioma growth
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2014.06.017
– volume: 25
  start-page: 402
  year: 2001
  ident: key20200713100450_b19-etm-0-0-7680
  article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
– volume: 273
  start-page: 418
  year: 2013
  ident: key20200713100450_b7-etm-0-0-7680
  article-title: Green tea polyphenol, (−)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting β-catenin signaling
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1016/j.taap.2013.09.021
– volume: 190
  start-page: 533
  year: 2010
  ident: key20200713100450_b17-etm-0-0-7680
  article-title: Regulation of the autophagy protein LC3 by phosphorylation
  publication-title: J Cell Biol
  doi: 10.1083/jcb.201002108
– volume: 461
  start-page: 614
  year: 2009
  ident: key20200713100450_b18-etm-0-0-7680
  article-title: Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
  publication-title: Nature
  doi: 10.1038/nature08356
– volume: 37
  start-page: 1097
  year: 2016
  ident: key20200713100450_b6-etm-0-0-7680
  article-title: MSX1 inhibits cell migration and invasion through regulating the Wnt/β-catenin pathway in glioblastoma
  publication-title: Tumour Biol
  doi: 10.1007/s13277-015-3892-2
– volume: 15
  start-page: 1656
  year: 2016
  ident: key20200713100450_b21-etm-0-0-7680
  article-title: MSK1-mediated β-catenin phosphorylation confers resistance to PI3K/mTOR inhibitors in glioblastoma
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-15-0857
– volume: 360
  start-page: 76
  year: 2015
  ident: key20200713100450_b23-etm-0-0-7680
  article-title: miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2015.02.003
– volume: 35
  start-page: 610
  year: 2009
  ident: key20200713100450_b12-etm-0-0-7680
  article-title: miR-24 inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to ‘seedless’ 3′UTR microRNA recognition elements
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2009.08.020
– volume: 11
  start-page: 318
  year: 2017
  ident: key20200713100450_b26-etm-0-0-7680
  article-title: Targeting WNT signaling for multifaceted glioblastoma therapy
  publication-title: Front Cell Neurosci
  doi: 10.3389/fncel.2017.00318
– volume: 151
  start-page: 157
  year: 2004
  ident: key20200713100450_b4-etm-0-0-7680
  article-title: Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2004.06048.x
– volume: 39
  start-page: 1387
  year: 2016
  ident: key20200713100450_b25-etm-0-0-7680
  article-title: PGRN suppresses inflammation and promotes autophagy in keratinocytes through the Wnt/β-catenin signaling pathway
  publication-title: Inflammation
  doi: 10.1007/s10753-016-0370-y
– volume: 239
  start-page: 297
  year: 2016
  ident: key20200713100450_b20-etm-0-0-7680
  article-title: Prostate tumour overexpressed-1 promotes tumourigenicity in human breast cancer via activation of Wnt/β-catenin signalling
  publication-title: J Pathol
  doi: 10.1002/path.4725
SSID ssj0000561885
Score 2.1881032
Snippet Mutations of the β-catenin gene are common in various cancer types. MicroRNA (miR)-24 suppresses gene expression during the cell cycle. However, the effects of...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1285
SubjectTerms Antibiotics
Apoptosis
Autophagy
Binding sites
Biotechnology
Brain cancer
Cell adhesion & migration
Cell cycle
Cell growth
Colorectal cancer
Glioma
Kinases
Laboratory animals
Liver cancer
Lung cancer
Medical prognosis
Mutation
Prostate cancer
Protein expression
Proteins
Skin cancer
Tumors
Title β‑catenin regulates effects of miR‑24 on the viability and autophagy of glioma cells
URI https://www.ncbi.nlm.nih.gov/pubmed/31316620
https://www.proquest.com/docview/2260941268
https://www.proquest.com/docview/2259909457
https://pubmed.ncbi.nlm.nih.gov/PMC6601135
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwELYoXHqp2tLHtoCMhPa0LhvbsZNTVSoQQgKtECvtLbIdh0YCB8hupf1b_SH9TZ1Jstluq_bsUV7feF4Zf0PIEUAMblgJVhRgAqUaW2as1iyysY0EuDjfTG-4vFLnU3kxi2ddwa3u2ipXNrEx1HnlsEZ-DGECZCIRV8nnh0eGU6Pw72o3QuMZ2UHqMtRqPdN9jQWj46SZyglqx9k4TaKWZhO8ND_2czyJHqWfIOIeb7qlv2LNP1smf_NBZy_Jiy54pF9atF-RLR9ek-GkZZ9ejujN-jBVPaJDOlnzUi93yfTnD4b9T6EM9KkdQe9r2jV00Kqg9-U145JWgUJUSL-XLYX3kpqQU7NABgJzu0TB27uyujcUi_71GzI9O735es66qQrMCRnPmfC84Mal0hRaKJunPi50ohTkXUoliUudtBbCBOOki41yujB5bO3Y6hy52XPxlmyHKvj3hGJuaLjhAiSkSVIL5sF6keQqlyaVbkBGq4-auY5yHCdf3GWQeiAGGWCQIQYZYjAgw178oeXa-Jfg3gqhrNtydbZWkAE57Jdhs-DHMMFXC5SJwfuCeuoBedcC2t9JRCJSisPF9QbUvQAScW-uhPJbQ8itIKuNRPzh_4_1kTzHN2i7B_fI9vxp4fchopnbg0ZtD8jOyenV5PoX8m73xQ
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOcAF8WZpASPBntY0sR0nOSCEgGpLH6rQrrS3YDtOidQmbbMLyp_iwA_hNzGzeSwLglvPGTmJvxnPjD3-hpAXADG4YSVYlsESKJVnmDZhyHwTGF-Ai3PL7g2HR2o8lR9nwWyDfO_uwmBZZbcmLhfqtLS4R74DYQJkIj5X0ZvzC4Zdo_B0tWuh0ajFvqu_QcpWvd57D_i-5Hz3w-TdmLVdBZgVMpgz4XjGtY2lzkKhTBq7IAsjpSDvUCqKbGylMeAmtZU20MqGmU4DYzwTpshNngoY9xq5Do7Xw2QvnIX9ng5G49GyCyioOWdeHPkNrSdEBXzHzfHmux-_ggjfW3eDf8W2f5Zo_ubzdm-TW22wSt822nWHbLjiLhkeN2zX9YhOVpe3qhEd0uMVD3Z9j0x__mBYb1XkBb1sWt67irYFJLTM6Fn-iXFJy4JCFEq_5g1leE11kVK9QMYDfVKj4MlpXp5piocM1X0yvZL5fkA2i7JwjwjFXFRzzQVISB3FBpYj40SUqlTqWNoBGXWTmtiW4hw7bZwmkOogBglgkCAGCWIwIMNe_Lzh9viX4HaHUNKaeJWsFHJAnvePwThxMnThygXKBODtwRzCAXnYANq_SfjCV4rD4OEa1L0AEn-vPynyL0sCcAVZtC-Cx___rGfkxnhyeJAc7B3tb5Gb-DdN5eI22ZxfLtwTiKbm5ulShSn5fNU28wswrjQn
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGJyFeEP8pDDAS9Kmmje04yQNCwFZtDKpqWqW9ZbbjlEhbMpYWlK_FIx-Cz8Rdk7QUBG97zslJ_Lvz3dnn3xHyAiAGN6wES1NYAqUaGqZNEDDP-MYT4OLcsnvDp7Han8oPJ_7JFvnR3oXBssp2TVwu1ElhcY98AGECZCIeV-EgbcoiJrujNxdfGHaQwpPWtp1GrSKHrvoG6Vv5-mAXsH7J-Wjv-P0-azoMMCukP2fC8ZRrG0mdBkKZJHJ-GoRKQQ6iVBjayEpjwGVqK62vlQ1SnfjGDE2QIE95ImDca2Q7wKyoQ7bf7Y0nR6sdHozNw2VPUFB6zoZR6NUknxAj8IGb4z14L3oF8f5w0yn-Fen-WbD5mwcc3SI3m9CVvq117TbZcvkd0pvU3NdVnx6vr3KVfdqjkzUrdnWXTH9-Z1h9lWc5vXQz7BrmStqUk9AipefZEeOSFjmFmJR-zWoC8YrqPKF6gfwHelah4OwsK841xSOH8h6ZXsmM3yedvMjdQ0IxM9VccwESUoeRgcXJOBEmKpE6krZL-u2kxrYhPMe-G2cxJD6IQQwYxIhBjBh0SW8lflEzffxLcKdFKG4MvozX6tklz1ePwVRxMnTuigXK-OD7wTiCLnlQA7p6k_CEpxSHwYMNqFcCSAO--STPPi_pwBXk1J7wH_3_s56R62Av8ceD8eFjcgN_pi5j3CGd-eXCPYHQam6eNjpMyelVm80vjdg5wg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%CE%B2%E2%80%91catenin+regulates+effects+of+miR%E2%80%9124+on+the+viability+and+autophagy+of+glioma+cells&rft.jtitle=Experimental+and+therapeutic+medicine&rft.au=Chen%2C+Hanchun&rft.au=Lu%2C+Qiong&rft.au=Chen%2C+Chao&rft.au=Di%2C+Yunhai&rft.date=2019-08-01&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892%2Fetm.2019.7680&rft.externalDBID=n%2Fa&rft.externalDocID=10_3892_etm_2019_7680
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1792-0981&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1792-0981&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1792-0981&client=summon